Copyright: ©Author(s) 2026.
World J Crit Care Med. Sep 9, 2026; 15(3): 120560
Published online Sep 9, 2026. doi: 10.5492/wjccm.120560
Published online Sep 9, 2026. doi: 10.5492/wjccm.120560
Table 1 Comparison of traditional scoring systems vs machine learning models in sepsis prognostication
| Feature | Traditional scores (SOFA, APACHE II, SAPS II) | Machine learning models (CatBoost, random forest, XGBoost, DeepAISE) |
| Data utilization | Uses static data, typically the worst values recorded within the first 24 hours of ICU admission[6] | Utilizes continuous, dynamic, real-time data streams including high-frequency vital signs and lab trends[18,20] |
| Data types | Limited to predefined structured physiological variables and lab values | Capable of processing structured data, unstructured clinical notes (via NLP), and multi-omics data[12,17] |
| Handling of complexity | Assumes linear relationships between physiological variables and patient outcomes[39] | Capable of modeling highly complex, non-linear interactions among high-dimensional data points[24] |
| Performance in oncology | Often inadequate due to lack of cancer-specific variables; altered baselines in cytopenic patients skew results[4,5] | Highly adaptable; incorporates cancer-specific comorbidities, treatment history, and specific biomarkers (e.g., blood urea nitrogen, red cell distribution width)[3,4] |
| Interpretability | Transparent, simple point-based systems; easily calculated manually at the bedside | Inherently “black box”; requires explainable AI techniques like SHAP or LIME to translate logic to clinicians[35] |
| Application | Retrospective severity assessment and general benchmarking | Real-time early warning alerts, dynamic mortality probability, and personalized treatment recommendations[39] |
Table 2 Key artificial intelligence applications and methodologies in onco-critical care sepsis
| Clinical application | Key AI/ML algorithms used | Primary data inputs | Demonstrated clinical impact |
| Early prediction of bacteremia in neutropenia | Random forest, XGBoost, Support vector machines | Routine hematological parameters (complete blood count + differential blood count trends), demographics[2,19] | Predicts bacterial growth 2-5 days prior to culture results, reducing indiscriminate use of broad-spectrum antibiotics[2] |
| Early warning of septic shock | DeepAISE (recurrent neural survival model), CNN-LSTM | Moving time-windows of vital signs, continuous EHR physiological data[15,17] | Identifies patient deterioration up to 12-24 hours before clinical onset, facilitating early administration of antimicrobials[20,25] |
| Integration of clinical notes | Latent Dirichlet allocation, natural language processing | Free-text physician progress notes, unstructured EHR data[17] | Captures physician intuition and nuanced clinical status; significantly improves accuracy of predictions 12-48 hours ahead of onset[17] |
| ICU mortality prediction | CatBoost, LightGBM, gradient boosting decision trees | Age, minimum blood urea nitrogen, urine output, red cell distribution width, metastasis status, SOFA/APS III[3,4] | Outperforms APACHE II/SOFA (AUC > 0.82-0.94); informs end-of-life and goals-of-care discussions[4,27,39] |
| Treatment optimization | Reinforcement learning digital twins | Historical treatment data, fluid balances, vasopressor responses[3,40] | Optimizes individual fluid resuscitation and vasopressor titration, preventing volume overload and reducing mortality[3] |
Table 3 Common clinical variables and biomarkers utilized by machine learning models for sepsis prediction in oncology patients
| Data category | Specific variables/features included | Clinical relevance in onco-critical care |
| Demographics and medical history | Age, gender, primary cancer type, metastatic status, history of solid organ or bone marrow transplant, prior chemotherapy regimens | Captures baseline physiological reserve, specific immunosuppressive states, and the inherent mortality risk associated with the patient’s underlying malignancy[4,27] |
| High-frequency vital signs | Heart rate, respiratory rate, temperature (max/minute/avg), systolic/diastolic blood pressure, peripheral oxygen saturation | Continuous streams of this data allow algorithms to detect subtle, non-linear trajectories of deterioration hours before a clinical diagnosis of septic shock[14] |
| Routine laboratory findings | Complete blood count (absolute neutrophil count, platelet count), red cell distribution width, hematocrit | Dynamic shifts in complete blood count parameters, particularly absolute neutrophil count and red cell distribution width, are powerful predictors of bacteremia and mortality in patients with chemotherapy-induced myelosuppression[2] |
| Metabolic and organ function markers | Minimum/maximum lactate, blood urea nitrogen, serum creatinine, bilirubin, minimum pH, base excess | Highlights critical sepsis-induced organ dysfunction, particularly acute kidney injury which is a major mortality driver in cancer patients receiving nephrotoxic drugs[4,14] |
| Inflammatory biomarkers | C-reactive protein, procalcitonin, interleukin-6 | Aids the model in differentiating between non-infectious tumor fevers (or drug reactions) and true bacterial sepsis[13,28] |
| Unstructured EHR data | Free-text physician progress notes, nursing assessments, radiology reports | Analyzed via natural language processing, these notes capture nuanced clinical intuition and symptom descriptions that structured numerical data misses[23] |
Table 4 Key barriers and proposed solutions for the clinical implementation of artificial intelligence in the oncology intensive care unit
| Implementation barrier | Description and clinical impact | Proposed solutions and emerging strategies |
| The “black box” phenomenon | Deep learning and complex ensemble models lack transparency, making clinicians hesitant to trust or act upon life-altering predictions without understanding the underlying reasoning[3,9] | Implementation of explainable AI tools (e.g., SHAP, LIME) to visualize feature importance; use of intrinsically transparent models like Bayesian Networks[24,35] |
| Data heterogeneity and domain shift | Models trained on general ICU populations (e.g., MIMIC databases) often perform poorly on highly specific subgroups like hematologic malignancy patients due to physiological differences[3,7] | Development of diverse, multi-center datasets; specific local recalibration of models; utilizing federated learning to train models across institutions while preserving data privacy[3,24] |
| Alert fatigue and workflow disruption | Overly sensitive algorithms generate excessive false-positive alarms, overwhelming staff and leading clinicians to ultimately ignore the system[9,11] | Calibrating models for higher specificity and positive predictive value; embedding alerts seamlessly into the EHR workflow; human-in-the-loop system designs[9,21] |
| Class imbalance in datasets | In hospital datasets, the number of patients dying from sepsis is significantly lower than the number of survivors, causing ML models to become biased toward predicting survival[17,39] | Utilizing data preprocessing techniques such as the synthetic minority over-sampling technique to synthetically balance the dataset during the training phase[17,39] |
| Lack of prospective validation | The vast majority of current models are based on retrospective observational data, lacking the rigorous evidence required to prove they safely improve patient outcomes[9,18] | Conducting large-scale, multi-center randomized controlled trials specifically assessing the safety, efficacy, and ethical integration of AI-driven clinical decision support systems[9,21] |
- Citation: Sirohiya P, Maurya P, Arora S, Ratre BK, Singh R, Kumar B. Artificial intelligence for early sepsis detection and dynamic prognostication in onco-critical care. World J Crit Care Med 2026; 15(3): 120560
- URL: https://www.wjgnet.com/2220-3141/full/v15/i3/120560.htm
- DOI: https://dx.doi.org/10.5492/wjccm.120560